These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 442215

  • 1. VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lung.
    Eagan RT, Creagan ET, Ingle JN, Rubin J, Frytak S, Kvols LK, Fleming TR.
    Tumori; 1979 Feb 28; 65(1):105-9. PubMed ID: 442215
    [Abstract] [Full Text] [Related]

  • 2. cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung.
    Sierocki JS, Hilaris BS, Hopfan S, Martini N, Barton D, Golbey RB, Wittes RE.
    Cancer Treat Rep; 1979 Feb 28; 63(9-10):1593-7. PubMed ID: 227598
    [Abstract] [Full Text] [Related]

  • 3. Etoposide alone and in combination with cyclophosphamide, adriamycin and cis-platinum in patients with Mo and Mi non-small-cell lung cancer.
    Eagan RT.
    Cancer Treat Rev; 1982 Jun 28; 9 Suppl():119-31. PubMed ID: 6889917
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. VP-16 and adriamycin in patients with advanced breast cancer.
    Vaughn CB, Maniscalco-Greb E, Lockhard C, Groshko G, Enochs K, Duffin H, Demitrish M.
    Am J Clin Oncol; 1982 Oct 28; 5(5):505-9. PubMed ID: 6897491
    [Abstract] [Full Text] [Related]

  • 8. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE, Crowley JJ, Blasko JC, Livingston RB, Beck TM, Demattia MD, Bukowski RM.
    J Clin Oncol; 1990 Jan 28; 8(1):39-47. PubMed ID: 2153194
    [Abstract] [Full Text] [Related]

  • 9. VP 16-213 (VP 16) and cyclophosphamide in the treatment of primitive lung cancer in phase M 1.
    Estape J, Milla A, Agusti A, Lloret JS, Palacin A, Soriano E.
    Cancer; 1979 Jan 28; 43(1):72-7. PubMed ID: 761177
    [Abstract] [Full Text] [Related]

  • 10. An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer.
    Rubin J, Decker DA, Ahmann DL, Eagan RT, Ingle JN, Hahn RG.
    Oncology; 1980 Jan 28; 37(3):149-51. PubMed ID: 7360486
    [Abstract] [Full Text] [Related]

  • 11. cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung.
    Britell JC, Eagan RT, Ingle JN, Creagen ET, Rubin J, Frytak S.
    Cancer Treat Rep; 1978 Aug 28; 62(8):1207-10. PubMed ID: 688256
    [Abstract] [Full Text] [Related]

  • 12. High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer.
    Lamar RE, Greco FA, Johnson DH, Murphy PB, Hainsworth JD.
    Cancer; 1994 Apr 01; 73(7):1842-8. PubMed ID: 8137208
    [Abstract] [Full Text] [Related]

  • 13. Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung.
    Eagan RT, Frytak S, Ingle JN, Creagan ET, Nichols WC, Kvols LK.
    Cancer Treat Rep; 1980 Apr 01; 64(8-9):925-8. PubMed ID: 7192602
    [Abstract] [Full Text] [Related]

  • 14. Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung.
    Eagan RT, Frytak S, Creagan ET, Ingle JN, Kvols LK, Coles DT.
    Cancer Treat Rep; 1979 Apr 01; 63(9-10):1589-91. PubMed ID: 227597
    [No Abstract] [Full Text] [Related]

  • 15. Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancer.
    Goldhirsch A, Joss RA, Cavalli F, Sonntag RW, Brunner KW.
    Med Pediatr Oncol; 1981 Apr 01; 9(3):205-8. PubMed ID: 6264280
    [Abstract] [Full Text] [Related]

  • 16. Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lung.
    Shaw EG, Frytak S, Eagan RT, Richardson RL, Creagan ET, Jett JR, Foote RL, Su JQ, Schaid DJ, Lee RE.
    Am J Clin Oncol; 1996 Apr 01; 19(2):154-8. PubMed ID: 8610640
    [Abstract] [Full Text] [Related]

  • 17. Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK).
    Joss RA, Alberto P, Hürny C, Bacchi M, Leyvraz S, Thürlimann B, Cerny T, Martinelli G, Stahel R, Ludwig C.
    Ann Oncol; 1995 Jan 01; 6(1):41-8. PubMed ID: 7536028
    [Abstract] [Full Text] [Related]

  • 18. VP-16-213 in combination chemotherapy with chest irradiation for small-cell lung cancer: a randomized trial of the Piedmont Oncology Association.
    Jackson DV, Zekan PJ, Caldwell RD, Slatkoff ML, Harding RW, Case LD, Hopkins JO, Muss HB, Richards F, White DR.
    J Clin Oncol; 1984 Dec 01; 2(12):1343-51. PubMed ID: 6096517
    [Abstract] [Full Text] [Related]

  • 19. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
    Ryssel HJ, Hasler E, Sonntag RW, Cavalli F, Martin J, Tschopp L, Brunner KW.
    Schweiz Med Wochenschr; 1977 Jul 02; 107(26):912-5. PubMed ID: 877537
    [Abstract] [Full Text] [Related]

  • 20. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
    Ohnoshi T, Hiraki S, Ueoka H, Kiura K, Kamei H, Horiguchi T, Kodani T, Maeda T, Tabata M, Shibayama T.
    Cancer; 1993 Sep 01; 72(5):1597-601. PubMed ID: 8394202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.